Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01602575 · ClinicalTrials.gov registry record · NA

Neuroimaging and Biomarkers in Chronic Visceral Pain

A NA study of Irritable Bowel Syndrome, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
119
Enrollment target
1
Study location

NCT01602575 is a NA study of Irritable Bowel Syndrome that has completed, run by University of California, Los Angeles. The registered enrollment target is 119 participants, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (16% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01602575, a NA study of Irritable Bowel Syndrome, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to use functional magnetic resonance imaging (fMRI) to evaluate brain resting state networks, responses to abdominal stimuli and the effect of MBSR Training on these measures. The goal of this study is to identify biomarkers of IBS and assess the responsiveness these biomarkers after MBSR Training. A biomarker, or biological marker, is in general a substance or measure used as an indicator of a biological state. It is a characteristic that is measured and evaluated as an indicator of normal biological processes, disease processes, or responses to a therapeutic intervention, in this case MBSR.

Conditions Studied

Interventions

  • BEHAVIORAL Mindfulness based Stress Reduction Training (MBSR)

Study Locations (1)

California

  • Oppenheimer Center for Neurobiology of Stress - Los Angeles

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2013-01
Est. Completion 2018-03-20
Phase NA

What the Registry Record Tells You About NCT01602575

The ClinicalTrials.gov registry entry for NCT01602575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 47 other Irritable Bowel Syndrome trials with a reported enrollment target (16% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Irritable Bowel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness based Stress Reduction Training (MBSR) is the first listed.

NCT01602575 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01602575 about?

NCT01602575 is a clinical study titled "Neuroimaging and Biomarkers in Chronic Visceral Pain". The purpose of this study is to use functional magnetic resonance imaging (fMRI) to evaluate brain resting state networks, responses to abdominal stimuli and the effect of MBSR Training on these measures. The goal of this study is to identify biomarkers of IBS and assess the responsiveness these bio...

What is the current status of trial NCT01602575?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2013-01. Estimated completion is 2018-03-20.

What conditions does trial NCT01602575 study?

This clinical trial studies the following conditions: Irritable Bowel Syndrome.

What interventions are being tested in trial NCT01602575?

The interventions under investigation include: Mindfulness based Stress Reduction Training (MBSR) (BEHAVIORAL).

Who is sponsoring clinical trial NCT01602575?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01602575 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Irritable Bowel Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.